Clinical Trial Update: Combined Immunotherapies in Metastatic ER+ Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase 2 study evaluating combined immunotherapies for metastatic estrogen receptor-positive breast cancer, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING